Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 22:12:630385.
doi: 10.3389/fphar.2021.630385. eCollection 2021.

Isoliensinine: A Natural Compound with "Drug-Like" Potential

Affiliations
Review

Isoliensinine: A Natural Compound with "Drug-Like" Potential

Yan Cheng et al. Front Pharmacol. .

Abstract

Isoliensinine, a bisbenzylisoquinoline alkaloid isolated from Nelumbo nucifera Gaertn, exerts a variety of beneficial effects, such as antitumor, cardioprotective, antioxidant, antidepressant, and anti-HIV effects, and ameliorates T2DM with hyperlipidemia and Alzheimer's disease. In this article, the recent literature on isoliensinine, including its pharmacology, pharmacokinetics, and synthesis and extraction, is summarized. Moreover, possible future prospects and research directions are also discussed. Studies on isoliensinine were found by searching a combination of keywords including "pharmacology," "pharmacokinetics," and "synthesis and extraction" in the main databases, including PubMed, Google Scholar, Web of Science, NCBI, and Wan Fang. Many studies have pointed out that a major limitation of isoliensinine is its poor solubility in aqueous media. Considering its advantages and limitations, isoliensinine can be used as a lead compound to develop novel efficient and low-toxicity derivatives. The available literature indicates that isoliensinine displays "drug-like" potential. Additionally, there are many related issues and novel mechanisms that need to be explored.

Keywords: isoliensinine; mechanism; pharmacokinetics; pharmacology; synthesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Abu Samaan T. M., Samec M., Liskova A., Kubatka P., Büsselberg D. (2019). Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer. Biomolecules 9 (12), 789. 10.3390/biom9120789 - DOI - PMC - PubMed
    1. Antzelevitch C., Nesterenko V., Shryock J. C., Rajamani S., Song Y., Belardinelli L. (2014). The Role of Late I Na in Development of Cardiac Arrhythmias. Handb Exp. Pharmacol. 221, 137–168. 10.1007/978-3-642-41588-3_7 - DOI - PMC - PubMed
    1. Apel K., Hirt H. (2004). Reactive Oxygen Species: Metabolism, Oxidative Stress, and Signal Transduction. Annu. Rev. Plant Biol. 55, 373–399. 10.1146/annurev.arplant.55.031903.141701 - DOI - PubMed
    1. Ashley E. A., Pyae Phyo A., Woodrow C. J. (2018). Malaria. Lancet 391 (10130), 1608–1621. 10.1016/s0140-6736(18)30324-6 - DOI - PubMed
    1. Barnett R. (2019). Alzheimer's Disease. Lancet 393 (10181), 1589. 10.1016/s0140-6736(19)30851-7 - DOI - PubMed

LinkOut - more resources